Tech Center 1600 • Art Units: 1600 1641 1644 1646 1649 1678 1699
This examiner grants 49% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17913629 | MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF | Non-Final OA | AMGEN INC. |
| 18019228 | COMPOSITIONS AND METHODS OF PREDICTING TIME TO ONSET OF LABOR | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17314376 | SARS-COV-2 IMMUNOASSAY AND MATERIALS THEREFOR | Final Rejection | BIO-RAD LABORATORIES, INC. |
| 18542382 | METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16302429 | ACOUSTIC SEPARATION FOR BIOPROCESSING | Final Rejection | THE CHARLES STARK DRAPER LABORATORY, INC. |
| 18865369 | METHODS FOR QUANTITATING VIRAL CAPSIDS | Non-Final OA | Sartorius BioAnalytical Instruments, Inc. |
| 17631598 | ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER | Final Rejection | Medizinische Hochschule Hannover |
| 18734732 | Capture Beads for Use in Assays | Non-Final OA | Zafrens Inc. |
| 18041141 | NANOPARTICLE-ENABLED ANALYSIS OF CELL-FREE NUCLEIC ACID IN COMPLEX BIOLOGICAL FLUIDS | Non-Final OA | THE UNIVERSITY OF MANCHESTER |
| 17257968 | Methods for Multicolor Multiplex Imaging | Non-Final OA | Ultivue, Inc. |
| 18025763 | Methods of Determining Immune Response | Non-Final OA | The Council of the Queensland Institute of Medical Research |
| 18248505 | PROTEOME ANALYSIS IN PULMONARY HYPERTENSION | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18466187 | COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTING | Non-Final OA | Biomerica, Inc. |
| 18548043 | METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C | Non-Final OA | INSTITUTO DE INVESTIGACIÓN SANITARIA INCLIVA |
| 18259727 | SURFACE ENHANCED RAMAN SPECTROSCOPIC METHODS FOR DETECTING ANALYTES | Non-Final OA | Johns Hopkins University |
| 18265584 | METHOD FOR PREDICTING THE FERTILITY POTENTIAL OF A FEMALE SUBJECT | Non-Final OA | Rigshospitalet |
| 17605656 | METHOD FOR DIAGNOSING ENDOMETRIOSIS, DISEASE STATE MONITORING METHOD, AND KIT | Non-Final OA | National Institutes of Biomedical Innovation, Health and Nutrition |
| 18311895 | METHODS OF ISOLATING AND DETECTING VIRUSES FROM LIQUID WITH POSSIBILITY OF CONTAINING VIRUSES | Non-Final OA | JNC CORPORATION |
| 18068872 | COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS | Non-Final OA | AMUNIX PHARMACEUTICALS, INC. |
| 18058171 | MULTIPLEXED FLUORESCENCE IN SITU HYBRIDIZATION METHOD CAPABLE OF RAPID DETECTION OF BILLIONS OF TARGETS | Non-Final OA | Kanvas Biosciences, Inc. |
| 17927187 | METHOD FOR EVALUATING ALLERGEN INACTIVATORS AND KIT FOR EVALUATING ALLERGEN INACTIVATORS | Non-Final OA | ITEA INC. |
| 17937251 | SURFACE FUNCTIONALIZED AFFINITY MEMBRANES | Non-Final OA | NANOPAREIL, LLC |
| 17692804 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | Non-Final OA | BERTIS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy